Patheon plans to restructure its network of six pharmaceutical manufacturing facilities in southern ON, Canada as part of its strategy to focus on developing and manufacturing prescription pharmaceutical products and to improve profitability. The company plans to divest its Niagara-Burlington Operations business, which is focused on the manufacturing of over-the-counter (OTC) products, with facilities in Fort Erie and Burlington Gateway and the commercial operations at Burlington Century. T...